explore -WSS

explore

author：hotspot 2025-10-04 11:57:21 - browse：275

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial

WSS

FDA scientists endorse Pfizer/BioNTech Covid

'Null' research findings aren't empty of meaning. Let's publish them

Late stage cancers on the rise after pandemic delayed screenings

Chris Christie meets with Zelenskyy during Ukraine trip

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

The a glaring gap in research on serious mental illness and primary care

hotspot

explore

focus

Virginia high school admissions case could be legal follow

Biotech lab space demand falls sharply

Affirmative action in medical school literally saved lives

How I helped Pfizer think through the ethics of Viagra

Sports medicine is finally prioritizing gender equality

Microbiome research is starting to find links to chronic diseases

The cancer drug shortage isn’t new — and neither are the solutions

Biotech lab space demand falls sharply

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Physicians aren't 'burning out.' They're suffering from moral injury

focus

Biotech startup Celsius cuts 75% of staff ahead of first trial start

'Null' research findings aren't empty of meaning. Let's publish them

Pharma showers House GOP doctor with campaign cash

The a glaring gap in research on serious mental illness and primary care

Experts study whether long Covid risk adds up with each reinfection

Lasker Awards 2023: Winners in biomedical research

leisure time

focus

knowledge

Wikipedia